{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:56:55Z","timestamp":1789790215748,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Oral Sci"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Interferon-\u03b3 (IFN-\u03b3), a key effector molecule in anti-tumor immune response, has been well documented to correlate with the intratumoral infiltration of immune cells. Of interest, however, a high level of IFN-\u03b3 has been reported in salivary adenoid cystic carcinoma (SACC), which is actually a type of immunologically cold cancer with few infiltrated immune cells. Investigating the functional significance of IFN-\u03b3 in SACC would help to explain such a paradoxical phenomenon. In the present study, we revealed that, compared to oral squamous cell carcinoma cells (a type of immunologically hot cancer), SACC cells were less sensitive to the growth-inhibition effect of IFN-\u03b3. Moreover, the migration and invasion abilities of SACC cells were obviously enhanced upon IFN-\u03b3 treatment. In addition, our results revealed that exposure to IFN-\u03b3 significantly up-regulated the level of programmed death ligand 1 (PD-L1) on SACC cell-derived small extracellular vesicles (sEVs), which subsequently induced the apoptosis of CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells through antagonizing PD-1. Importantly, it was also found that SACC patients with higher levels of plasma IFN-\u03b3 also had higher levels of circulating sEVs that carried PD-L1 on their surface. Our study unveils a mechanism that IFN-\u03b3 induces immunosuppression in SACC via sEV PD-L1, which would account for the scarce immune cell infiltration and insensitivity to immunotherapy.\n                  <\/jats:p>","DOI":"10.1038\/s41368-022-00197-x","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T22:02:27Z","timestamp":1664316147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Interferon-\u03b3 induces immunosuppression in salivary adenoid cystic carcinoma by regulating programmed death ligand 1 secretion"],"prefix":"10.1038","volume":"14","author":[{"given":"Qiuyun","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houfu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuepeng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3332-3511","authenticated-orcid":false,"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"197_CR1","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/annonc\/mdx399","volume":"28","author":"J Ross","year":"2017","unstructured":"Ross, J. et al. Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies. Ann. Oncol. 28, 2539\u20132546 (2017).","journal-title":"Ann. Oncol."},{"key":"197_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.oraloncology.2018.11.028","volume":"88","author":"C Mosconi","year":"2019","unstructured":"Mosconi, C. et al. Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands. Oral. Oncol. 88, 95\u2013101 (2019).","journal-title":"Oral. Oncol."},{"key":"197_CR3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S0002-9610(05)80721-4","volume":"164","author":"R Spiro","year":"1992","unstructured":"Spiro, R. & Huvos, A. Stage means more than grade in adenoid cystic carcinoma. Am. J. Surg. 164, 623\u2013628 (1992).","journal-title":"Am. J. Surg."},{"key":"197_CR4","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/hed.10126","volume":"24","author":"J van der Wal","year":"2002","unstructured":"van der Wal, J., Becking, A., Snow, G. & van der Waal, I. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head. Neck. 24, 779\u2013783 (2002).","journal-title":"Head. Neck."},{"key":"197_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.oraloncology.2013.05.004","volume":"49","author":"S van Weert","year":"2013","unstructured":"van Weert, S. et al. Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period. Oral. Oncol. 49, 824\u2013829 (2013).","journal-title":"Oral. Oncol."},{"key":"197_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.oooo.2018.01.013","volume":"125","author":"R Cordesmeyer","year":"2018","unstructured":"Cordesmeyer, R. et al. The incidence of occult metastasis and the status of elective neck dissection in salivary adenoid cystic carcinoma: a single center study. Oral. Surg. Oral. Med Oral. Pathol. Oral. Radiol. 125, 516\u2013519 (2018).","journal-title":"Oral. Surg. Oral. Med Oral. Pathol. Oral. Radiol."},{"key":"197_CR7","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1172\/JCI80011","volume":"125","author":"L Chen","year":"2015","unstructured":"Chen, L. & Han, X. Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future. J. Clin. Invest. 125, 3384\u20133391 (2015).","journal-title":"J. Clin. Invest."},{"key":"197_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/COC.0000000000000429","volume":"41","author":"R Cohen","year":"2018","unstructured":"Cohen, R. et al. Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study. Am. J. Clin. Oncol. 41, 1083\u20131088 (2018).","journal-title":"Am. J. Clin. Oncol."},{"key":"197_CR9","doi-asserted-by":"publisher","first-page":"104359","DOI":"10.1016\/j.oraloncology.2019.07.002","volume":"101","author":"S Kokkali","year":"2020","unstructured":"Kokkali, S. et al. Nivolumab in patients with rare head and neck carcinomas: A single center\u2019s experience. Oral. Oncol. 101, 104359 (2020).","journal-title":"Oral. Oncol."},{"key":"197_CR10","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ijrobp.2020.08.018","volume":"109","author":"U Mahmood","year":"2021","unstructured":"Mahmood, U. et al. A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 109, 134\u2013144 (2021).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"197_CR11","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1158\/1078-0432.CCR-19-2214","volume":"26","author":"CP Rodriguez","year":"2020","unstructured":"Rodriguez, C. P. et al. A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer. Clin. Cancer Res. 26, 837\u2013845 (2020).","journal-title":"Clin. Cancer Res."},{"key":"197_CR12","doi-asserted-by":"publisher","first-page":"5884","DOI":"10.1073\/pnas.85.16.5884","volume":"85","author":"Y Shirayoshi","year":"1988","unstructured":"Shirayoshi, Y., Burke, P. A., Appella, E. & Ozato, K. Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence. Proc. Natl Acad. Sci. USA. 85, 5884\u20135888 (1988).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"197_CR13","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4049\/jimmunol.142.3.999","volume":"142","author":"I Amaldi","year":"1989","unstructured":"Amaldi, I., Reith, W., Berte, C. & Mach, B. Induction of HLA class II genes by IFN-gamma is transcriptional and requires a trans-acting protein. J. Immunol. 142, 999\u20131004 (1989).","journal-title":"J. Immunol."},{"key":"197_CR14","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/j.molimm.2007.01.009","volume":"44","author":"M Zhao","year":"2007","unstructured":"Zhao, M. et al. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma. Mol. Immunol. 44, 2923\u20132932 (2007).","journal-title":"Mol. Immunol."},{"key":"197_CR15","first-page":"5245","volume":"59","author":"S Mukai","year":"1999","unstructured":"Mukai, S., Kjaergaard, J., Shu, S. & Plautz, G. Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res. 59, 5245\u20135249 (1999).","journal-title":"Cancer Res."},{"key":"197_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<552::AID-PATH469>3.0.CO;2-I","volume":"189","author":"M Kunz","year":"1999","unstructured":"Kunz, M. et al. Strong expression of the lymphoattractant C-X-C chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma. J. Pathol. 189, 552\u2013558 (1999).","journal-title":"J. Pathol."},{"key":"197_CR17","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/hed.20533","volume":"29","author":"T Hoffmann","year":"2007","unstructured":"Hoffmann, T. et al. Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck. Head. Neck. 29, 472\u2013478 (2007).","journal-title":"Head. Neck."},{"key":"197_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong, H. et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8, 793\u2013800 (2002).","journal-title":"Nat. Med."},{"key":"197_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12943-019-1049-4","volume":"18","author":"W Feng","year":"2019","unstructured":"Feng, W. et al. Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol. Cancer. 18, 124 (2019).","journal-title":"Mol. Cancer."},{"key":"197_CR20","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. The biology function and biomedical applications of exosomes. Science. 367, eaau6977 (2020).","journal-title":"Science."},{"key":"197_CR21","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 7, 1535750 (2018).","journal-title":"J. Extracell. Vesicles."},{"key":"197_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 560, 382\u2013386 (2018).","journal-title":"Nature."},{"key":"197_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko, I. & Blanpain, C. EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol. 29, 212\u2013226 (2019).","journal-title":"Trends Cell Biol."},{"key":"197_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene, B. & Berx, G. Regulatory networks defining EMT during cancer initiation and progression. Nat. Rev. Cancer 13, 97\u2013110 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"197_CR25","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"J Thiery","year":"2002","unstructured":"Thiery, J. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer. 2, 442\u2013454 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"197_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.ceb.2013.04.008","volume":"25","author":"M Marks","year":"2013","unstructured":"Marks, M., Heijnen, H. & Raposo, G. Lysosome-related organelles: unusual compartments become mainstream. Curr. Opin. Cell Biol. 25, 495\u2013505 (2013).","journal-title":"Curr. Opin. Cell Biol."},{"key":"197_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1083\/jcb.201601025","volume":"214","author":"S Sinha","year":"2016","unstructured":"Sinha, S. et al. Cortactin promotes exosome secretion by controlling branched actin dynamics. J. Cell Biol. 214, 197\u2013213 (2016).","journal-title":"J. Cell Biol."},{"key":"197_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski, M. et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19\u201330 (2010).","journal-title":"Nat. Cell Biol."},{"key":"197_CR29","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/331086a0","volume":"331","author":"M Makgoba","year":"1988","unstructured":"Makgoba, M. et al. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature. 331, 86\u201388 (1988).","journal-title":"Nature"},{"key":"197_CR30","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1158\/2326-6066.CIR-18-0940","volume":"7","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. Systemic Interferon-\u03b3 Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical Trial. Cancer Immunol. Res. 7, 1237\u20131243 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"197_CR31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00262-016-1881-y","volume":"65","author":"IS Mauldin","year":"2016","unstructured":"Mauldin, I. S. et al. Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases. Cancer Immunol. Immunother. 65, 1189\u20131199 (2016).","journal-title":"Cancer Immunol. Immunother."},{"key":"197_CR32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2022","unstructured":"Kohli, K., Pillarisetty, V. G. & Kim, T. S. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther. 29, 10\u201321 (2022).","journal-title":"Cancer Gene Ther."},{"key":"197_CR33","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","volume":"95","author":"DH Kaplan","year":"1998","unstructured":"Kaplan, D. H. et al. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc. Natl Acad. Sci. USA. 95, 7556\u20137561 (1998).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"197_CR34","first-page":"5818","volume":"48","author":"JS Weber","year":"1988","unstructured":"Weber, J. S. & Rosenberg, S. A. Modulation of murine tumor major histocompatibility antigens by cytokines in vivo and in vitro. Cancer Res. 48, 5818\u20135824 (1988).","journal-title":"Cancer Res."},{"key":"197_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1158\/2326-6066.CIR-16-0031","volume":"4","author":"V Sridharan","year":"2016","unstructured":"Sridharan, V. et al. Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes. Cancer Immunol. Res. 4, 679\u2013687 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"197_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jss.2019.02.038","volume":"240","author":"D Imai","year":"2019","unstructured":"Imai, D. et al. IFN-\u03b3 Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer. J. Surg. Res. 240, 115\u2013123 (2019).","journal-title":"J. Surg. Res."},{"key":"197_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.tranon.2017.11.008","volume":"11","author":"YH Xu","year":"2018","unstructured":"Xu, Y. H., Li, Z. L. & Qiu, S. F. IFN-\u03b3 Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin \u03b23-Mediated NF-\u03baB Signaling. Transl. Oncol. 11, 182\u2013192 (2018).","journal-title":"Transl. Oncol."},{"key":"197_CR38","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1073\/pnas.84.10.3405","volume":"84","author":"K Taniguchi","year":"1987","unstructured":"Taniguchi, K. et al. Interferon gamma induces lung colonization by intravenously inoculated B16 melanoma cells in parallel with enhanced expression of class I major histocompatibility complex antigens. Proc. Natl Acad. Sci. USA. 84, 3405\u20133409 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"197_CR39","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1158\/1078-0432.1010.11.3","volume":"11","author":"J Kim","year":"2005","unstructured":"Kim, J. et al. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin. Cancer Res. 11, 1010\u20131020 (2005).","journal-title":"Clin. Cancer Res."},{"key":"197_CR40","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.4049\/jimmunol.0900970","volume":"183","author":"E Wieckowski","year":"2009","unstructured":"Wieckowski, E. et al. Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J. Immunol. 183, 3720\u20133730 (2009).","journal-title":"J. Immunol."},{"key":"197_CR41","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.7150\/thno.19712","volume":"7","author":"WW Yang","year":"2017","unstructured":"Yang, W. W. et al. Epiregulin Promotes Lung Metastasis of Salivary Adenoid Cystic Carcinoma. Theranostics. 7, 3700\u20133714 (2017).","journal-title":"Theranostics"},{"key":"197_CR42","doi-asserted-by":"crossref","unstructured":"Th\u00e9ry, C., Amigorena, S., Raposo, G. & Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Ch.3.22 (2006).","DOI":"10.1002\/0471143030.cb0322s30"},{"key":"197_CR43","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo, M., Raposo, G. & Th\u00e9ry, C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255\u2013289 (2014).","journal-title":"Annu. Rev. Cell Dev. Biol."}],"container-title":["International Journal of Oral Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41368-022-00197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41368-022-00197-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41368-022-00197-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T16:29:58Z","timestamp":1676910598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41368-022-00197-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["197"],"URL":"https:\/\/doi.org\/10.1038\/s41368-022-00197-x","relation":{},"ISSN":["1674-2818","2049-3169"],"issn-type":[{"value":"1674-2818","type":"print"},{"value":"2049-3169","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"15 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}